Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEGACY trial of aspirin omission after PCI in NSTE-ACS
NL-OMON54035Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin, ticagrelor and prasugrel in acute coronary syndrome (ACS), sponsored by Amsterdam University Medical Center. Started May 2022; status: recruiting.
02
Drugs
aspirinticagrelorprasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NL-OMON54035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54035.